Abstract
Epstein-Barr virus (EBV) will infect at least every third cell if exposed in vitro to an extensively purified B cell population from human peripheral blood. About 10% of such infected cells will be driven into immunoglobulin synthesis and secretion, as judged by the indirect protein A plaque assay. The appearance of EB nuclear antigen, de novo DNA synthesis, and immunoglobulin secretion are linked phenomena accompanying infection as judged by viral dilution experiments, which yield kinetics of a one-hit order. Induction of immunoglobulin secretion in B cells by EBV requires de novo synthesis of DNA, and consequently, nontransforming EBV (P3HR1) will not induce immunoglobulin secretion and will also specifically block such induction from subsequently added EBV. The termination of immunoglobulin induction by EBV in short-term cultures appears to be T cell dependent.
Full Text
The Full Text of this article is available as a PDF (422.6 KB).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Andersson U., Bird G., Britton S. Cellular mechanisms of restricted immunoglobulin formation in the human neonate. Eur J Immunol. 1980 Nov;10(11):888–894. doi: 10.1002/eji.1830101115. [DOI] [PubMed] [Google Scholar]
- Bird A. G., Britton S. A live human B-cell activator operating in isolation of other cellular influences. Scand J Immunol. 1979;9(6):507–510. doi: 10.1111/j.1365-3083.1979.tb03278.x. [DOI] [PubMed] [Google Scholar]
- Bird A. G., Britton S. A new approach to the study of human B lymphocyte function using an indirect plaque assay and a direct B cell activator. Immunol Rev. 1979;45:41–67. doi: 10.1111/j.1600-065x.1979.tb00272.x. [DOI] [PubMed] [Google Scholar]
- Chen W. Y., Muñoz J., Fudenberg H. H., Tung E., Virella G. Polyclonal activation of human peripheral blood B lymphocytes by formaldehyde-fixed Salmonella paratyphi B. I. Immunoglobulin production without DNA synthesis. J Exp Med. 1981 Feb 1;153(2):365–374. doi: 10.1084/jem.153.2.365. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Diehl V., Henle G., Henle W., Kohn G. Demonstration of a herpes group virus in cultures of peripheral leukocytes from patients with infectious mononucleosis. J Virol. 1968 Jul;2(7):663–669. doi: 10.1128/jvi.2.7.663-669.1968. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Einhorn L., Ernberg I. Induction of EBNA precedes the first cellular S-phase after EBV-infection of human lymphocytes. Int J Cancer. 1978 Feb 15;21(2):157–160. doi: 10.1002/ijc.2910210205. [DOI] [PubMed] [Google Scholar]
- Einhorn L., Steinitz M., Yefenof E., Ernberg I., Bakacs T., Klein G. Epstein-Barr virus (EBV) receptors, complement receptors, and EBV infectibility of different lymphocyte fractions of human peripheral blood. II. Epstein-Barr virus studies. Cell Immunol. 1978 Jan;35(1):43–58. doi: 10.1016/0008-8749(78)90125-9. [DOI] [PubMed] [Google Scholar]
- Epstein M. A., Achong B. G. Various forms of Epstein-Barr virus infection in man: established facts and a general concept. Lancet. 1973 Oct 13;2(7833):836–839. doi: 10.1016/s0140-6736(73)90874-x. [DOI] [PubMed] [Google Scholar]
- Gronowicz E. S., Doss C., Schröder J. Activation to IgG secretion by lipopolysaccharide requires several proliferation cycles. J Immunol. 1979 Nov;123(5):2057–2062. [PubMed] [Google Scholar]
- Hinuma Y., Konn M., Yamaguchi J., Wudarski D. J., Blakeslee J. R., Jr, Grace J. T., Jr Immunofluorescence and herpes-type virus particles in the P3HR-1 Burkitt lymphoma cell line. J Virol. 1967 Oct;1(5):1045–1051. doi: 10.1128/jvi.1.5.1045-1051.1967. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Miller G., Lipman M. Comparison of the yield of infectious virus from clones of human and simian lymphoblastoid lines transformed by Epstein-Barr virus. J Exp Med. 1973 Dec 1;138(6):1398–1412. doi: 10.1084/jem.138.6.1398. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Nilsson K., Klein G., Henle W., Henle G. The establishment of lymphoblastoid lines from adult and fetal human lymphoid tissue and its dependence on EBV. Int J Cancer. 1971 Nov 15;8(3):443–450. doi: 10.1002/ijc.2910080312. [DOI] [PubMed] [Google Scholar]
- Reedman B. M., Klein G. Cellular localization of an Epstein-Barr virus (EBV)-associated complement-fixing antigen in producer and non-producer lymphoblastoid cell lines. Int J Cancer. 1973 May;11(3):499–520. doi: 10.1002/ijc.2910110302. [DOI] [PubMed] [Google Scholar]
- Rickinson A. B., Finerty S., Epstein M. A. Comparative studies on adult donor lymphocytes infected by EB virus in vivo or in vitro: origin of transformed cells arising in co-cultures with foetal lymphocytes. Int J Cancer. 1977 Jun 15;19(6):775–782. doi: 10.1002/ijc.2910190606. [DOI] [PubMed] [Google Scholar]
- Robinson J., Smith D., Niederman J. Mitotic EBNA-positive lymphocytes in peripheral blood during infectious mononucleosis. Nature. 1980 Sep 25;287(5780):334–335. doi: 10.1038/287334a0. [DOI] [PubMed] [Google Scholar]
- Steinitz M., Bakács T., Yefenof E., Klein G. Inhibition of DNA metabolism in human B lymphocytes by a substrain of Epstein-Barr virus (P3HR-1): a method for virus quantitation. Intervirology. 1978;10(2):125–131. doi: 10.1159/000148977. [DOI] [PubMed] [Google Scholar]
- Thorley-Lawson D. A. The suppression of Epstein-Barr virus infection in vitro occurs after infection but before transformation of the cell. J Immunol. 1980 Feb;124(2):745–751. [PubMed] [Google Scholar]